- Home
- WYY vs TPST Comparison
WYY vs TPST Comparison
Compare WYY & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- TPST
- Stock Information
- Founded
- WYY 1991
- TPST 2011
- Country
- WYY United States
- TPST United States
- Employees
- WYY N/A
- TPST N/A
- Industry
- WYY EDP Services
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- WYY Technology
- TPST Health Care
- Exchange
- WYY Nasdaq
- TPST Nasdaq
- Market Cap
- WYY 37.8M
- TPST 40.4M
- IPO Year
- WYY 1998
- TPST N/A
- Fundamental
- Price
- WYY $3.45
- TPST $0.83
- Analyst Decision
- WYY Strong Buy
- TPST Strong Buy
- Analyst Count
- WYY 1
- TPST 3
- Target Price
- WYY $7.00
- TPST $21.67
- AVG Volume (30 Days)
- WYY 27.7K
- TPST 618.1K
- Earning Date
- WYY 03-26-2025
- TPST 05-08-2025
- Dividend Yield
- WYY N/A
- TPST N/A
- EPS Growth
- WYY N/A
- TPST N/A
- EPS
- WYY N/A
- TPST N/A
- Revenue
- WYY $133,124,648.00
- TPST N/A
- Revenue This Year
- WYY $28.46
- TPST N/A
- Revenue Next Year
- WYY $12.97
- TPST N/A
- P/E Ratio
- WYY N/A
- TPST N/A
- Revenue Growth
- WYY 31.67
- TPST N/A
- 52 Week Low
- WYY $1.83
- TPST $0.70
- 52 Week High
- WYY $6.25
- TPST $6.00
- Technical
- Relative Strength Index (RSI)
- WYY 41.76
- TPST 47.67
- Support Level
- WYY $3.29
- TPST $0.77
- Resistance Level
- WYY $3.72
- TPST $0.85
- Average True Range (ATR)
- WYY 0.26
- TPST 0.05
- MACD
- WYY -0.01
- TPST 0.00
- Stochastic Oscillator
- WYY 29.29
- TPST 62.16
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically the company generates a majority of its revenue from the United States and rest from Europe.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.